CRNX vs FIS · rev $7.7M vs P/E 7.9, rev $6.67B
Crinetics Pharmaceuticals Inc (CRNX) versus Fidelity National Information Services Inc (FIS) — a side-by-side from cached financials, not a winner call.
Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
Latest reported CRNX revenue for 2025-12-31 was $7.7M. Net income was -$465.3M. CRNX currently screens at market cap $2.76B.
Latest reported FIS revenue for 2026-06-30 was $6.67B. Net income was $2.60B. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
CRNX currently screens at market cap $2.76B. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Not investment advice. Open the CRNX and FIS stock pages for the full models.
Not investment advice.